Global Placental Stem Cell Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 84

Published Date: 01 Apr 2021

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Placental Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Placental Stem Cell Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Placental Stem Cell Therapy market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Placental Stem Cell Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Hematologic Malignancies and Disorders
    Congenital Immunodeficiency Disorders
    Metabolic Disorders
    Neurological Disorders
    Others

Market segment by Application, can be divided into
    Hospitals and Specialty Clinics
    Clinical Research Organizations
    Research Institutes and Academies
    Others

Market segment by players, this report covers
    Lifebank Stem Cell Banking
    Cynata
    Celularity
    Athersys
    Americord Registry
    ReNeuron Group
    ReeLabs
    Mesoblast
    Pluristem Therapeutics

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Placental Stem Cell Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Placental Stem Cell Therapy, with revenue, gross margin and global market share of Placental Stem Cell Therapy from 2019 to 2021.
Chapter 3, the Placental Stem Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Placental Stem Cell Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Placental Stem Cell Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Placental Stem Cell Therapy
    1.2 Classification of Placental Stem Cell Therapy by Type
        1.2.1 Overview: Global Placental Stem Cell Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Placental Stem Cell Therapy Revenue Market Share by Type in 2020
        1.2.3 Hematologic Malignancies and Disorders
        1.2.4 Congenital Immunodeficiency Disorders
        1.2.5 Metabolic Disorders
        1.2.6 Neurological Disorders
        1.2.7 Others
    1.3 Global Placental Stem Cell Therapy Market by Application
        1.3.1 Overview: Global Placental Stem Cell Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals and Specialty Clinics
        1.3.3 Clinical Research Organizations
        1.3.4 Research Institutes and Academies
        1.3.5 Others
    1.4 Global Placental Stem Cell Therapy Market Size & Forecast
    1.5 Global Placental Stem Cell Therapy Market Size and Forecast by Region
        1.5.1 Global Placental Stem Cell Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Placental Stem Cell Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Placental Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Placental Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Placental Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Placental Stem Cell Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Placental Stem Cell Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Placental Stem Cell Therapy Market Drivers
        1.6.2 Placental Stem Cell Therapy Market Restraints
        1.6.3 Placental Stem Cell Therapy Trends Analysis

2 Company Profiles
    2.1 Lifebank Stem Cell Banking
        2.1.1 Lifebank Stem Cell Banking Details
        2.1.2 Lifebank Stem Cell Banking Major Business
        2.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
        2.1.4 Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Lifebank Stem Cell Banking Recent Developments and Future Plans
    2.2 Cynata
        2.2.1 Cynata Details
        2.2.2 Cynata Major Business
        2.2.3 Cynata Placental Stem Cell Therapy Product and Solutions
        2.2.4 Cynata Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Cynata Recent Developments and Future Plans
    2.3 Celularity
        2.3.1 Celularity Details
        2.3.2 Celularity Major Business
        2.3.3 Celularity Placental Stem Cell Therapy Product and Solutions
        2.3.4 Celularity Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Celularity Recent Developments and Future Plans
    2.4 Athersys
        2.4.1 Athersys Details
        2.4.2 Athersys Major Business
        2.4.3 Athersys Placental Stem Cell Therapy Product and Solutions
        2.4.4 Athersys Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Athersys Recent Developments and Future Plans
    2.5 Americord Registry
        2.5.1 Americord Registry Details
        2.5.2 Americord Registry Major Business
        2.5.3 Americord Registry Placental Stem Cell Therapy Product and Solutions
        2.5.4 Americord Registry Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Americord Registry Recent Developments and Future Plans
    2.6 ReNeuron Group
        2.6.1 ReNeuron Group Details
        2.6.2 ReNeuron Group Major Business
        2.6.3 ReNeuron Group Placental Stem Cell Therapy Product and Solutions
        2.6.4 ReNeuron Group Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 ReNeuron Group Recent Developments and Future Plans
    2.7 ReeLabs
        2.7.1 ReeLabs Details
        2.7.2 ReeLabs Major Business
        2.7.3 ReeLabs Placental Stem Cell Therapy Product and Solutions
        2.7.4 ReeLabs Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 ReeLabs Recent Developments and Future Plans
    2.8 Mesoblast
        2.8.1 Mesoblast Details
        2.8.2 Mesoblast Major Business
        2.8.3 Mesoblast Placental Stem Cell Therapy Product and Solutions
        2.8.4 Mesoblast Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Mesoblast Recent Developments and Future Plans
    2.9 Pluristem Therapeutics
        2.9.1 Pluristem Therapeutics Details
        2.9.2 Pluristem Therapeutics Major Business
        2.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
        2.9.4 Pluristem Therapeutics Placental Stem Cell Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Pluristem Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Placental Stem Cell Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Placental Stem Cell Therapy Players Market Share
        3.2.2 Top 10 Placental Stem Cell Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Placental Stem Cell Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Placental Stem Cell Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Placental Stem Cell Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Placental Stem Cell Therapy Revenue Market Share by Application (2016-2021)
    5.2 Placental Stem Cell Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Placental Stem Cell Therapy Revenue by Type (2016-2026)
    6.2 North America Placental Stem Cell Therapy Revenue by Application (2016-2026)
    6.3 North America Placental Stem Cell Therapy Market Size by Country
        6.3.1 North America Placental Stem Cell Therapy Revenue by Country (2016-2026)
        6.3.2 United States Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Placental Stem Cell Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Placental Stem Cell Therapy Revenue by Type (2016-2026)
    7.2 Europe Placental Stem Cell Therapy Revenue by Application (2016-2026)
    7.3 Europe Placental Stem Cell Therapy Market Size by Country
        7.3.1 Europe Placental Stem Cell Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Placental Stem Cell Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Placental Stem Cell Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Placental Stem Cell Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific Placental Stem Cell Therapy Revenue by Region (2016-2026)
        8.3.2 China Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Placental Stem Cell Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Placental Stem Cell Therapy Revenue by Type (2016-2026)
    9.2 South America Placental Stem Cell Therapy Revenue by Application (2016-2026)
    9.3 South America Placental Stem Cell Therapy Market Size by Country
        9.3.1 South America Placental Stem Cell Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Placental Stem Cell Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Placental Stem Cell Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Placental Stem Cell Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa Placental Stem Cell Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Placental Stem Cell Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Placental Stem Cell Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Placental Stem Cell Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Placental Stem Cell Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Placental Stem Cell Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Placental Stem Cell Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Placental Stem Cell Therapy Revenue Market Share by Region (2021-2026)
    Table 6. Lifebank Stem Cell Banking Corporate Information, Head Office, and Major Competitors
    Table 7. Lifebank Stem Cell Banking Major Business
    Table 8. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product and Solutions
    Table 9. Lifebank Stem Cell Banking Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Cynata Corporate Information, Head Office, and Major Competitors
    Table 11. Cynata Major Business
    Table 12. Cynata Placental Stem Cell Therapy Product and Solutions
    Table 13. Cynata Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Celularity Corporate Information, Head Office, and Major Competitors
    Table 15. Celularity Major Business
    Table 16. Celularity Placental Stem Cell Therapy Product and Solutions
    Table 17. Celularity Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Athersys Corporate Information, Head Office, and Major Competitors
    Table 19. Athersys Major Business
    Table 20. Athersys Placental Stem Cell Therapy Product and Solutions
    Table 21. Athersys Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Americord Registry Corporate Information, Head Office, and Major Competitors
    Table 23. Americord Registry Major Business
    Table 24. Americord Registry Placental Stem Cell Therapy Product and Solutions
    Table 25. Americord Registry Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. ReNeuron Group Corporate Information, Head Office, and Major Competitors
    Table 27. ReNeuron Group Major Business
    Table 28. ReNeuron Group Placental Stem Cell Therapy Product and Solutions
    Table 29. ReNeuron Group Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. ReeLabs Corporate Information, Head Office, and Major Competitors
    Table 31. ReeLabs Major Business
    Table 32. ReeLabs Placental Stem Cell Therapy Product and Solutions
    Table 33. ReeLabs Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Mesoblast Corporate Information, Head Office, and Major Competitors
    Table 35. Mesoblast Major Business
    Table 36. Mesoblast Placental Stem Cell Therapy Product and Solutions
    Table 37. Mesoblast Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Pluristem Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Pluristem Therapeutics Major Business
    Table 40. Pluristem Therapeutics Placental Stem Cell Therapy Product and Solutions
    Table 41. Pluristem Therapeutics Placental Stem Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Global Placental Stem Cell Therapy Revenue (USD Million) by Players (2019-2021)
    Table 43. Global Placental Stem Cell Therapy Revenue Share by Players (2019-2021)
    Table 44. Breakdown of Placental Stem Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 45. Placental Stem Cell Therapy Players Head Office, Products and Services Provided
    Table 46. Placental Stem Cell Therapy Mergers & Acquisitions in the Past Five Years
    Table 47. Placental Stem Cell Therapy New Entrants and Expansion Plans
    Table 48. Global Placental Stem Cell Therapy Revenue (USD Million) by Type (2016-2021)
    Table 49. Global Placental Stem Cell Therapy Revenue Share by Type (2016-2021)
    Table 50. Global Placental Stem Cell Therapy Revenue Forecast by Type (2021-2026)
    Table 51. Global Placental Stem Cell Therapy Revenue by Application (2016-2021)
    Table 52. Global Placental Stem Cell Therapy Revenue Forecast by Application (2021-2026)
    Table 53. North America Placental Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 54. North America Placental Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 55. North America Placental Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 56. North America Placental Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 57. North America Placental Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 58. North America Placental Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 59. Europe Placental Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 60. Europe Placental Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 61. Europe Placental Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 62. Europe Placental Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 63. Europe Placental Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 64. Europe Placental Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 65. Asia-Pacific Placental Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 66. Asia-Pacific Placental Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 67. Asia-Pacific Placental Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 68. Asia-Pacific Placental Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 69. Asia-Pacific Placental Stem Cell Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 70. Asia-Pacific Placental Stem Cell Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 71. South America Placental Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 72. South America Placental Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 73. South America Placental Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 74. South America Placental Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 75. South America Placental Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 76. South America Placental Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 77. Middle East & Africa Placental Stem Cell Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 78. Middle East & Africa Placental Stem Cell Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 79. Middle East & Africa Placental Stem Cell Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 80. Middle East & Africa Placental Stem Cell Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 81. Middle East & Africa Placental Stem Cell Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 82. Middle East & Africa Placental Stem Cell Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Placental Stem Cell Therapy Picture
    Figure 2. Global Placental Stem Cell Therapy Revenue Market Share by Type in 2020
    Figure 3. Hematologic Malignancies and Disorders
    Figure 4. Congenital Immunodeficiency Disorders
    Figure 5. Metabolic Disorders
    Figure 6. Neurological Disorders
    Figure 7. Others
    Figure 8. Placental Stem Cell Therapy Revenue Market Share by Application in 2020
    Figure 9. Hospitals and Specialty Clinics Picture
    Figure 10. Clinical Research Organizations Picture
    Figure 11. Research Institutes and Academies Picture
    Figure 12. Others Picture
    Figure 13. Global Placental Stem Cell Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global Placental Stem Cell Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global Placental Stem Cell Therapy Revenue Market Share by Region (2016-2026)
    Figure 16. Global Placental Stem Cell Therapy Revenue Market Share by Region in 2020
    Figure 17. North America Placental Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe Placental Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific Placental Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America Placental Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa Placental Stem Cell Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Placental Stem Cell Therapy Market Drivers
    Figure 23. Placental Stem Cell Therapy Market Restraints
    Figure 24. Placental Stem Cell Therapy Market Trends
    Figure 25. Lifebank Stem Cell Banking Recent Developments and Future Plans
    Figure 26. Cynata Recent Developments and Future Plans
    Figure 27. Celularity Recent Developments and Future Plans
    Figure 28. Athersys Recent Developments and Future Plans
    Figure 29. Americord Registry Recent Developments and Future Plans
    Figure 30. ReNeuron Group Recent Developments and Future Plans
    Figure 31. ReeLabs Recent Developments and Future Plans
    Figure 32. Mesoblast Recent Developments and Future Plans
    Figure 33. Pluristem Therapeutics Recent Developments and Future Plans
    Figure 34. Global Placental Stem Cell Therapy Revenue Share by Players in 2020
    Figure 35. Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 36. Global Top 3 Players Placental Stem Cell Therapy Revenue Market Share in 2020
    Figure 37. Global Top 10 Players Placental Stem Cell Therapy Revenue Market Share in 2020
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 39. Global Placental Stem Cell Therapy Revenue Share by Type in 2020
    Figure 40. Global Placental Stem Cell Therapy Market Share Forecast by Type (2021-2026)
    Figure 41. Global Placental Stem Cell Therapy Revenue Share by Application in 2020
    Figure 42. Global Placental Stem Cell Therapy Market Share Forecast by Application (2021-2026)
    Figure 43. North America Placental Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 44. North America Placental Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 45. North America Placental Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 46. United States Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 47. Canada Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. Mexico Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. Europe Placental Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 50. Europe Placental Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 51. Europe Placental Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 52. Germany Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. France Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. United Kingdom Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Russia Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Italy Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. Asia-Pacific Placental Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 58. Asia-Pacific Placental Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 59. Asia-Pacific Placental Stem Cell Therapy Revenue Market Share by Region (2016-2026)
    Figure 60. China Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Japan Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. South Korea Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. India Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Southeast Asia Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Australia Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South America Placental Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 67. South America Placental Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 68. South America Placental Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East and Africa Placental Stem Cell Therapy Sales Market Share by Type (2016-2026)
    Figure 72. Middle East and Africa Placental Stem Cell Therapy Sales Market Share by Application (2016-2026)
    Figure 73. Middle East and Africa Placental Stem Cell Therapy Revenue Market Share by Country (2016-2026)
    Figure 74. Turkey Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Saudi Arabia Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. UAE Placental Stem Cell Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics

Related Reports

Global Placental Stem Cell Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Placental Stem Cell Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022